# Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve.

> **NCT06737016** · PHASE3 · RECRUITING · sponsor: **Mansoura University** · enrollment: 50 (estimated)

## Conditions studied

- Posterior Urethral Valve

## Interventions

- **DRUG:** Tamsulosin
- **DRUG:** Oxybutynin
- **DRUG:** Trimethoprim/sulfamethoxazole (TMP/SMZ)

## Key facts

- **NCT ID:** NCT06737016
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2026-05
- **Final completion:** 2026-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06737016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06737016, "Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06737016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*